Hospital Brigadeiro

São Paulo SP01401-901

0 studies enrolling now · 4 studies all time

What they study most

Hepatocellular Carcinoma, Liver Decompensation, Non-Hodgkin Lymphoma, Non-Hodgkin's Lymphoma, Partial Epilepsy, Refractory Partial Seizures

Studies at this site

• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed
• Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures — Completed
• The Second Multicenter Hemophilia Cohort Study — Completed
• Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma — Completed